Catherine W. Kohn VMD , Stephen M. Reed DVM , Cheryl D. Sofaly DVM, MS , Richard W. Henninger DVM, MS , William J. Saville DVM, PhD , George P. Allen PhD , Christopher Premanadan DVM
{"title":"Transmission of EHV-1 by Horses with EHV-1 Myeloencephalopathy: Implications for Biosecurity and Review","authors":"Catherine W. Kohn VMD , Stephen M. Reed DVM , Cheryl D. Sofaly DVM, MS , Richard W. Henninger DVM, MS , William J. Saville DVM, PhD , George P. Allen PhD , Christopher Premanadan DVM","doi":"10.1053/j.ctep.2006.01.011","DOIUrl":null,"url":null,"abstract":"<div><p>Although myeloencehalopathy due to Equine Herpesvirus-1 occurs infrequently, multiple horses may be affected during an outbreak and mortality may be high. In January of 2003, six horses from a large outbreak of EHV-1 respiratory and neurological disease were referred to The Ohio State University Veterinary Teaching Hospital for treatment of incapacitating myeloencephalopathy. Following introduction of these horses, we documented transmission of EHV-1 to five bystander horses in our hospital and indirectly to a sixth horse at a distant site. We concluded that one or more of the horses from the outbreak was shedding EHV-1 while displaying signs of myeloencephalopathy. Our experiences demonstrated the erroneous nature of the commonly held assumption that horses with EHV-1 myeloencephalopathy are no longer shedding virus. Horses with EHV-1 myeloencephalopathy should be strictly quarantined. Vigorous biosecurity measures should be instituted, including quarantine of the affected premises for a minimum of 21 days following the last clinical evidence of active EHV-1 disease.</p></div>","PeriodicalId":100279,"journal":{"name":"Clinical Techniques in Equine Practice","volume":"5 1","pages":"Pages 60-66"},"PeriodicalIF":0.0000,"publicationDate":"2006-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/j.ctep.2006.01.011","citationCount":"29","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Techniques in Equine Practice","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1534751606000126","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 29
Abstract
Although myeloencehalopathy due to Equine Herpesvirus-1 occurs infrequently, multiple horses may be affected during an outbreak and mortality may be high. In January of 2003, six horses from a large outbreak of EHV-1 respiratory and neurological disease were referred to The Ohio State University Veterinary Teaching Hospital for treatment of incapacitating myeloencephalopathy. Following introduction of these horses, we documented transmission of EHV-1 to five bystander horses in our hospital and indirectly to a sixth horse at a distant site. We concluded that one or more of the horses from the outbreak was shedding EHV-1 while displaying signs of myeloencephalopathy. Our experiences demonstrated the erroneous nature of the commonly held assumption that horses with EHV-1 myeloencephalopathy are no longer shedding virus. Horses with EHV-1 myeloencephalopathy should be strictly quarantined. Vigorous biosecurity measures should be instituted, including quarantine of the affected premises for a minimum of 21 days following the last clinical evidence of active EHV-1 disease.